Hongjin Li's research focuses on reducing multiple symptoms (pain, fatigue, sleep disturbance, depression, anxiety, hot flashes) experienced by 4 million breast cancer survivors on endocrine therapy. She has received more than $8 million in grant funding and currently leading 2 NIH interdisciplinary funded research studies that test and implement complementary and integrative therapies (i.e., acupuncture) to alleviate cancer-related symptoms among medically underserved breast cancer survivors and use multi-omics approach to understand the effect and mechanism of acupuncture. Integration of Traditional Chinese Medicine and Western medicine has greatly advanced the mechanistic understanding of acupuncture and the identification of novel biomarkers for personalized acupuncture approaches to symptom management. Through pioneering work in acupuncture, she has been recognized as a consultant for the Illinois Joint Task Force of the Illinois Department of Human Services and the Illinois Society of Acupuncturists, specifically addressing Medicaid Reimbursement for Acupuncture. This pivotal involvement has led to the initiation of Medicaid coverage for acupuncture in Illinois. Dr. Li received her BSN from the University of Missouri St. Louis, her MS-biostatistics from Columbia University Mailman School of Public Health, PhD from the University of Pittsburgh College of Nursing and her Postdoctoral Fellowship from the University of Illinois Chicago College of Nursing.